• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

EyePoint, Inc. - Common Stock (NQ:EYPT)

4.870 -9.880 (-66.98%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 52,268,283
Open 4.060
Bid (Size) 4.800 (7,400)
Ask (Size) 4.810 (16,200)
Prev. Close 14.75
Today's Range 3.950 - 4.900
52wk Range 3.950 - 19.11
Shares Outstanding 34,984,044
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Let's take a look at the stocks that are in motion in today's session. ↗
August 17, 2026
Via Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
August 17, 2026
Via Chartmill

Performance

YTD
-72.1%
-72.1%
1 Month
-61.5%
-61.5%
3 Month
-58.4%
-58.4%
6 Month
-67.3%
-67.3%
1 Year
-57.0%
-57.0%

More News

Read More
News headline image
EyePoint’s DURAVYU Misses Primary Endpoint in Phase III Wet AMD Trial ↗
August 17, 2026
Via MarketBeat
There are notable gap-ups and gap-downs in today's session. ↗
August 17, 2026
Via Chartmill
EyePoint (NASDAQ:EYPT) Rallies Despite Wider Q2 Loss as Phase 3 Data Nears ↗
August 05, 2026
Via Chartmill
EyePoint Inc. (NASDAQ:EYPT) Revenue Beats Estimates, Earnings Miss in Q1 2026 Report ↗
May 06, 2026
Via Chartmill
Topics Earnings
EyePoint Inc (NASDAQ:EYPT) Stock Falls on Q4 Earnings and Revenue Miss ↗
March 04, 2026
Via Chartmill
These stocks are moving in today's pre-market session ↗
August 17, 2026
Via Chartmill
News headline image
Will SpaceX Stock Double Anytime Soon? No -- but These 3 Stocks Could ↗
June 29, 2026
Via The Motley Fool
News headline image
EyePoint Pharmaceuticals Eyes Transformative 2026 as DURAVYU Phase 3 Data Nears ↗
May 26, 2026
Via MarketBeat
News headline image
Alumis Stock Has Soared 400%. Cormorant Bought Another $8 Million Last Quarter ↗
May 17, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why This Fund Just Made a $55 Million Bet on Dianthus Amid a 350% Stock Rally ↗
May 17, 2026
Via The Motley Fool
News headline image
Erasca Stock Is Up 715%. Here’s Why One Biotech Fund Still Bought $68 Million More ↗
May 17, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
EyePoint (EYPT) Q1 2026 Earnings Transcript ↗
May 07, 2026
Via The Motley Fool
News headline image
This Fund Bought $28 Million of a Beaten-Down Immunotherapy Stock Last Quarter. What Should Long-Term Investors Know? ↗
March 16, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal ↗
March 16, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch ↗
March 16, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Biotech Stock Up 700% Is Still a Top Holding Despite a $9.3 Million Sale Last Quarter ↗
March 16, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment ↗
March 15, 2026
Via The Motley Fool
News headline image
EyePoint (EYPT) Q4 2025 Earnings Call Transcript ↗
March 04, 2026
Via The Motley Fool
Topics Earnings
News headline image
Retina’s ‘Sustained’ Moment: Ocular Therapeutix Braces for Game-Changing Phase 3 AXPAXLI Data
February 16, 2026
Via MarketMinute
News headline image
The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market
January 22, 2026
Via MarketMinute
Topics Artificial Intelligence ETFs Initial Public Offering
News headline image
Small-Cap Renaissance: Russell 2000 Scales New Heights While Big Tech Stumbles
January 08, 2026
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
The Great Rotation: Small Caps Lead the Charge as 2026 Trading Opens
January 02, 2026
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
The Small-Cap Renaissance: Why 2026 is the Year of the Russell 2000 and XSU
January 01, 2026
Via MarketMinute
Topics Artificial Intelligence ETFs Economy

Frequently Asked Questions

Is EyePoint, Inc. - Common Stock publicly traded?
Yes, EyePoint, Inc. - Common Stock is publicly traded.
What exchange does EyePoint, Inc. - Common Stock trade on?
EyePoint, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for EyePoint, Inc. - Common Stock?
The ticker symbol for EyePoint, Inc. - Common Stock is EYPT on the Nasdaq Stock Market
What is the current price of EyePoint, Inc. - Common Stock?
The current price of EyePoint, Inc. - Common Stock is 4.870
When was EyePoint, Inc. - Common Stock last traded?
The last trade of EyePoint, Inc. - Common Stock was at 08/17/26 04:00 PM ET
What is the market capitalization of EyePoint, Inc. - Common Stock?
The market capitalization of EyePoint, Inc. - Common Stock is 170.37M
How many shares of EyePoint, Inc. - Common Stock are outstanding?
EyePoint, Inc. - Common Stock has 170M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap